Imane Benabbad

805 total citations
17 papers, 102 citations indexed

About

Imane Benabbad is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Imane Benabbad has authored 17 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Imane Benabbad's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (7 papers) and Diabetes Management and Education (3 papers). Imane Benabbad is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (7 papers) and Diabetes Management and Education (3 papers). Imane Benabbad collaborates with scholars based in France, United States and Germany. Imane Benabbad's co-authors include Myriam Rosilio, Christopher J. Child, Nan Jia, Heike Jung, Judith L. Ross, Jean‐Claude Carel, Werner Blum, Cheri Deal, Paul‐Martin Holterhus and Christof Land and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

Imane Benabbad

16 papers receiving 98 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imane Benabbad France 5 76 42 33 20 15 17 102
Nicole Sheanon United States 7 71 0.9× 62 1.5× 45 1.4× 8 0.4× 29 1.9× 15 132
G Blondin France 5 27 0.4× 37 0.9× 46 1.4× 15 0.8× 20 1.3× 11 109
Samuel Liju India 8 31 0.4× 43 1.0× 44 1.3× 39 1.9× 27 1.8× 9 134
Amélie Poidvin France 7 87 1.1× 38 0.9× 15 0.5× 21 1.1× 39 2.6× 9 112
A. Donzeau France 8 88 1.2× 44 1.0× 18 0.5× 20 1.0× 51 3.4× 17 126
Barbara Felappi Italy 5 90 1.2× 58 1.4× 39 1.2× 25 1.3× 29 1.9× 6 120
Louise Denvir United Kingdom 6 27 0.4× 21 0.5× 15 0.5× 9 0.5× 11 0.7× 11 67
Roberto Mirasol Philippines 5 108 1.4× 38 0.9× 13 0.4× 7 0.3× 38 2.5× 21 138
A. Zborovskaya Belarus 3 47 0.6× 13 0.3× 15 0.5× 9 0.5× 15 1.0× 9 65
Divya Sri Priyanka Tallapragada India 5 29 0.4× 44 1.0× 26 0.8× 23 1.1× 37 2.5× 6 104

Countries citing papers authored by Imane Benabbad

Since Specialization
Citations

This map shows the geographic impact of Imane Benabbad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imane Benabbad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imane Benabbad more than expected).

Fields of papers citing papers by Imane Benabbad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imane Benabbad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imane Benabbad. The network helps show where Imane Benabbad may publish in the future.

Co-authorship network of co-authors of Imane Benabbad

This figure shows the co-authorship network connecting the top 25 collaborators of Imane Benabbad. A scholar is included among the top collaborators of Imane Benabbad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imane Benabbad. Imane Benabbad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Heerspink, Hiddo J.L., Allon N. Friedman, Petter Bjornstad, et al.. (2025). Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes. Journal of the American Society of Nephrology. 36(11). 2190–2200. 4 indexed citations
2.
Sattar, Naveed, et al.. (2024). Efficacy of tirzepatide in achieving the composite endpoints of glycemic, blood pressure and lipid goals in SURMOUNT-2. Obesity Research & Clinical Practice. 18(5). S34–S35. 1 indexed citations
3.
Heerspink, Hiddo J.L., Allon N. Friedman, Petter Bjornstad, et al.. (2024). 264-OR: Effect of Tirzepatide on Kidney Function in People with Excess Body Weight and Type 2 Diabetes—A Post-Hoc Analysis of the SURMOUNT-2 Trial. Diabetes. 73(Supplement_1). 1 indexed citations
4.
Naïditch, Nicolas, et al.. (2022). STYLCONNECT Study: An Assessment of Automatic Data Collection Devices by People Living with Diabetes and Using an Insulin Pen. Diabetes Therapy. 14(2). 303–318. 4 indexed citations
5.
Soulat, Louis, Imane Benabbad, Hélène Sapin, et al.. (2022). Utilization of emergency services for severe hypoglycemia in people with diabetes in France: A study based on the national health insurance database. SHILAP Revista de lepidopterología. 7. 100083–100083. 1 indexed citations
6.
Chevalier, Nicolas, Alfred Penfornis, Jean‐Pierre Riveline, et al.. (2021). Conversations and reactions around severe hypoglycemia (CRASH) global survey of people with type 1 diabetes or insulin-treated type 2 diabetes and caregivers: Findings from the French cohort. Annales d Endocrinologie. 83(1). 16–26. 2 indexed citations
7.
Chevalier, Nicolas, Imane Benabbad, Beth Mitchell, et al.. (2020). Étude mondiale CRASH (Conversations and Reactions Around Severe Hypoglycaemia) Résultats de la cohorte française des adultes ayant un diabète de type 1. Annales d Endocrinologie. 81(4). 259–260. 1 indexed citations
8.
Cosson, Emmanuel, et al.. (2019). <p>Perceptions of insulin therapy in people with type 2 diabetes and physicians: a cross-sectional survey conducted in France</p>. Patient Preference and Adherence. Volume 13. 251–260. 4 indexed citations
10.
Pfäffle, Roland, Christof Land, Eckhard Schönaü, et al.. (2018). Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS). Hormone Research in Paediatrics. 90(3). 169–180. 23 indexed citations
11.
Altman, Jean‐Jacques, Nicolas Chevalier, Brigitte Delemer, F. Travert, & Imane Benabbad. (2018). Développement des biosimilaires de l’insuline : exemple de l’insuline glargine LY2963016. La Presse Médicale. 47(10). 854–866.
12.
Benabbad, Imane, Myriam Rosilio, M. Tauber, et al.. (2018). Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature. Endocrine Connections. 7(5). 708–718. 14 indexed citations
13.
Auger, Julie, Amandine Baptiste, Imane Benabbad, et al.. (2016). Genotype-Phenotype Relationship in Patients and Relatives with <b><i>SHOX</i></b> Region Anomalies in the French Population. Hormone Research in Paediatrics. 86(5). 309–318. 4 indexed citations
14.
Benabbad, Imane, Myriam Rosilio, Christopher J. Child, et al.. (2016). Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial. Hormone Research in Paediatrics. 87(1). 42–50. 26 indexed citations
15.
Kaiserman, Kevin B., Heike Jung, Imane Benabbad, et al.. (2016). 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence. Pediatric Diabetes. 18(2). 81–94. 14 indexed citations
16.
Moyers, Julie S., Steven D. Kahl, Xiaoping Ruan, et al.. (2016). CA-019: Pharmacologie in vitro de LY IGlar (LY2963016, Insulin Glargine). Diabetes & Metabolism. 42. A40–A40. 1 indexed citations
17.
Benabbad, Imane, Hinde Iraqi, Badr Serji, et al.. (2010). Parathyroid incidentaloma. Literature review about three case reports. Annales d Endocrinologie. 72(1). 30–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026